Sutro Biopharma (STRO) PT Raised to $16 at Piper Sandler
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $20.48 --0%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff raised the price target on Sutro Biopharma (NASDAQ: STRO) to $16.00 (from $14.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Johnson Rice Downgrades Expand Energy (EXE) to Accumulate
- Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
